Body

A tailor made molecule against malaria

The malaria parasite is particularly pernicious since it is built to develop resistance to treatments. The lack of new therapeutic approaches also contributes to the persistence of this global scourge. A study led by Didier Picard, professor at the Faculty of Sciences of the University of Geneva (UNIGE), Switzerland, describes a new class of molecules targeting the two problems at the same time.

Back surgery offers long-term societal benefits, according to new study

Rosemont, Ill – Annually, more than 10 million people experience back pain in the United States. More than 200,000 of these patients undergo surgery to alleviate pain due to a herniated disc. Surgery to remove the disc has been found to be an effective way to improve these patients' quality of life in cases where conservative treatment is ineffective, but until now, little was known about the societal benefits of surgery and workplace productivity in particular.

New prognostic test for breast cancer could improve patient treatment

A study by researchers in Nottingham has developed a new clinical test for breast cancer which aims to improve patient treatment.

The Nottingham Prognostic Index Plus (NPI+) could be available to patients within two years.

The findings, published in the British Journal of Cancer today, could significantly improve the way in which breast cancer patients are treated by giving clinicians more detailed information about a patient's breast cancer type and its likely behaviour, which will help them create a more personalised treatment plan.

The first food web inside humans suggests potential new treatments for infection

Imagine going to the doctor with an infection and being sent home with a course of drugs. Unknown to your doctor you actually have two infections. If you take the drugs will the other infection go away by itself? What if you take the drugs and the other infection gets worse? This quandary faces those treating patients with multiple infections.

Experts urge Chancellor to 'crack down on cheap drink' in next week's budget

Writing on bmj.com, Katherine Brown, Director at the Institute of Alcohol Studies, says the UK chancellor should resist industry lobbying to scrap the annual rise in alcohol duty because "society simply can't afford for such cheap drink to get cheaper."

The duty escalator has been in place since 2008 to ensure that the price of alcohol rises at 2% above inflation. But a campaign by the wine and spirits industry is calling on the Chancellor to "Be Fair George!" and scrap the duty escalator for all alcohol in this year's budget.

Nicotine patches do not appear to help pregnant smokers to quit

Smoking during pregnancy increases the risk of adverse pregnancy and birth outcomes and may have long lasting effects in offspring.

In England, 26% of women smoke in the year before their pregnancy and 12% smoke through to delivery. The rate is similar or even higher in other high income countries.

Antibody could be used to target tumor-causing protein, study shows

CINCINNATI—Cincinnati Cancer Center (CCC) and University of Cincinnati (UC) Cancer Institute researchers have found in a phase-1 study that patients with advanced melanoma and kidney cancer who were treated with a certain antibody that targets a tumor-enhancing protein was safe, which could lead to more treatment options for patients.

The study is published in the March 11 edition of PLOS ONE, a peer-reviewed, open access online publication.

Examining potential of clinical applications of whole-genome sequencing

In an exploratory study involving 12 adults, the use of whole-genome sequencing (WGS) was associated with incomplete coverage of inherited-disease genes, low reproducibility of detection of genetic variation with the highest potential clinical effects, and uncertainty about clinically reportable findings, although in certain cases WGS will identify genetic variants warranting early medical intervention, according to a study in the March 12 issue of JAMA.

Discrepancies between trial results reported on clinical trial registry and in journals

During a one year period, among clinical trials published in high-impact journals that reported results on a public clinical trial registry (ClinicalTrials.gov), nearly all had at least 1 discrepancy in the study group, intervention, or results reported between the 2 sources, including discrepancies in the designated primary end points for the studies, according to a study in the March 12 issue of JAMA.

Study finds comparable outcomes for commonly used surgeries to treat vaginal prolapse

For women undergoing surgery for vaginal prolapse and stress urinary incontinence, neither of 2 common repair procedures was superior to the other for functional or adverse event outcomes, and behavioral therapy with pelvic muscle training did not improve urinary symptoms or prolapse outcomes after surgery, according to a study in the March 12 issue of JAMA.

Study examines development of peer review research in biomedicine

An analysis of research on peer review finds that studies aimed at improving methods of peer review and reporting of biomedical research are underrepresented and lack dedicated funding, according to a study in the March 12 issue of JAMA.

Discontinuation of randomized clinical trials common

Approximately 25 percent of about 1,000 randomized clinical trials initiated between 2000 and 2003 were discontinued, with the most common reason cited being poor recruitment of volunteers; and less than half of these trials reported the discontinuation to a research ethics committee, or were ever published, according to a study in the March 12 issue of JAMA.

Two surgeries for pelvic prolapse found similarly effective, safe

Two surgical treatments for a form of pelvic hernia affecting women have similar rates of success and safety, scientists in a National Institutes of Health research network have found. A guided exercise therapy to strengthen pelvic muscles did not add to the benefits of either surgery.

Incontinence and Prolapse procedures found to be comparable in women

MAYWOOD – Two common procedures to treat pelvic organ prolapse without vaginal mesh are comparable in safety and efficacy, according to research published in the latest issue of the Journal of the American Medical Association. Researchers also found that behavioral and pelvic floor muscle therapy (BPMT) did not improve urinary incontinence or prolapse symptoms in affected women.

Whole-genome sequencing for clinical use faces many challenges, Stanford study finds

STANFORD, Calif. — Whole-genome sequencing has been touted as a game-changer in personalized medicine. Clinicians can identify increases in disease risk for specific patients, as well as their responsiveness to certain drugs, by determining the sequence of the billions of building blocks, called nucleotides, that make up their DNA.